FDA Brief

Warning letters Devices

FDA warning letter to

Zhejiang Xichen Medical Technology Co., Ltd.

High riskIssued Jun 4, 2021Posted Jul 6, 2021Center for Devices and Radiological Health

FDA warned Zhejiang Xichen Medical Technology for selling three face masks in the U.S. without FDA clearance and for misleading FDA registration claims.

What happened

FDA reviewed the company's website on March 23, 2021, and found the FFP2 NR 5-Layer KN95 Face Mask, Medical Face Mask, and Sterile Surgical Mask offered for sale in the United States with claims to prevent COVID-19, infection, and bacteria. FDA said the masks lacked marketing approval, clearance, or authorization and that the site displayed an "FDA REGISTRATION CERTIFICATE" bearing the FDA logo, which falsely suggests FDA approval.

What FDA found

  1. The website claims the masks prevent COVID-19, infection, and bacteria, which makes them medical devices under the law.

    Section 201(h), 21 U.S.C. § 321(h)
  2. The masks are offered for sale in the U.S. with no approved premarket approval application or investigational device exemption, which makes them adulterated.

    Section 501(f)(1)(B), 21 U.S.C. § 351(f)(1)(B); sections 515(a) and 520(g)
  3. The company did not notify FDA of its intent to market the devices, which makes them misbranded.

    Section 502(o), 21 U.S.C. § 352(o); section 510(k)
  4. The site displays a certificate using the FDA logo and an FDA database screenshot that imply FDA approval or endorsement of the company and its masks.

    Section 502(a), 21 U.S.C. § 352(a); 21 CFR 807.39
  5. The Sterile Surgical Mask page states the product has a "Certificate CE, FDA," which further misleads buyers.

    Section 502(a), 21 U.S.C. § 352(a)

What FDA wants

FDA asked the company to immediately stop selling any adulterated or misbranded products intended to mitigate, prevent, treat, diagnose, or cure COVID-19, and to write back within 15 business days describing the corrective steps taken and how it will prevent repeat violations.

Who should pay attention

  • U.S. importers and distributors of foreign-made face masks
  • buyers who rely on supplier-issued "FDA registration certificates"
  • brands that private-label or resell PPE from overseas manufacturers

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. ZIIP, Inc.

    FDA warns ZIIP over quality-system violations and unapproved marketing of HALO 2.0, DOT, and gels.

    High risk
  2. Skytron, LLC

    Skytron marketed four UV disinfection devices without FDA clearance or approval and kept unapproved medical claims after promising to remove them.

    High risk
  3. Longhorn Vaccines and Diagnostics LLC

    Longhorn Vaccines and Diagnostics sold its PrimeStore MTM sample transport device without required quality controls or clearance for claims beyond its approved uses.

    High risk
  4. Les Encres LLC

    FDA warns Les Encres that its PDO surgical suture threads were promoted for unapproved cosmetic uses and had quality system violations.

    High risk